NASDAQ:TOI Oncology Institute (TOI) Stock Price, News & Analysis $0.53 -0.01 (-1.87%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.51▼$0.5650-Day Range$0.41▼$0.6152-Week Range$0.41▼$2.66Volume113,564 shsAverage Volume146,919 shsMarket Capitalization$39.14 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Oncology Institute alerts: Email Address Oncology Institute MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside375.5% Upside$2.50 Price TargetShort InterestHealthy0.83% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.08Based on 10 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.63) to ($0.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.70 out of 5 starsMedical Sector475th out of 936 stocksOffices & Clinics Of Medical Doctors Industry3rd out of 8 stocks 3.5 Analyst's Opinion Consensus RatingOncology Institute has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageOncology Institute has received no research coverage in the past 90 days.Read more about Oncology Institute's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.83% of the float of Oncology Institute has been sold short.Short Interest Ratio / Days to CoverOncology Institute has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Oncology Institute has recently decreased by 13.52%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOncology Institute does not currently pay a dividend.Dividend GrowthOncology Institute does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TOI. Previous Next 1.7 News and Social Media Coverage News SentimentOncology Institute has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Oncology Institute this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 2 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oncology Institute insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.50% of the stock of Oncology Institute is held by insiders.Percentage Held by InstitutionsOnly 36.86% of the stock of Oncology Institute is held by institutions.Read more about Oncology Institute's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Oncology Institute are expected to grow in the coming year, from ($0.63) to ($0.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Oncology Institute is -0.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oncology Institute is -0.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOncology Institute has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Oncology Institute's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Oncology Institute Stock (NASDAQ:TOI)The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.Read More TOI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TOI Stock News HeadlinesJuly 26 at 2:34 PM | msn.comAustralian researchers to now produce personalised cancer vaccinesJuly 25 at 9:02 PM | msn.comAI in healthcare: Is it the ultimate solution we have been waiting for?July 26, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.July 25 at 10:58 AM | msn.comTimes Internet launches TOI Health+, one stop destination for health, wellness updatesJuly 23 at 8:39 PM | msn.comBreakthrough at Israeli institute: Lifesaving treatment for world's deadliest cancerJuly 23 at 8:39 PM | yahoo.comNew cancer institute to be built in St. Johns County with help from incentives agreementJuly 23 at 9:41 AM | markets.businessinsider.comThe Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference CallJuly 20, 2024 | msn.comPreclinical study shows promise of systemic targeted therapy in a rare form of cancerJuly 26, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.July 20, 2024 | msn.comWhat are the most common symptoms before cancer is actually diagnosedJuly 19, 2024 | msn.comNorthside Hospital Cancer Institute offers GammaTile for brain tumorsMay 29, 2024 | globenewswire.comThe Oncology Institute to Participate at Upcoming Investor ConferencesMay 27, 2024 | msn.comKeep eye on neck swelling, doctors tell thyroid patientsMay 22, 2024 | globenewswire.comThe Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring ConferenceMay 19, 2024 | msn.comThe Oncology Institute, Inc. (NASDAQ:TOI) Q1 2024 Earnings Call TranscriptMay 17, 2024 | msn.comResearchers discover new pathway to cancer cell death from chemotherapyMay 17, 2024 | msn.comBurjeel Medical City partners with TII for cancer treatmentMay 16, 2024 | cbsnews.comNew Sylvester Brain Tumor Institute offering personalized treatmentSee More Headlines Receive TOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/26/2024Next Earnings (Confirmed)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryN/A Current SymbolNASDAQ:TOI CUSIPN/A CIK1799191 Webtheoncologyinstitute.com Phone562-735-3226FaxN/AEmployees800Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$2.50 Low Stock Price Target$2.50 Potential Upside/Downside+376.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-83,070,000.00 Net Margins-20.28% Pretax Margin-21.31% Return on Equity-109.10% Return on Assets-32.26% Debt Debt-to-Equity Ratio2.14 Current Ratio3.09 Quick Ratio2.83 Sales & Book Value Annual Sales$324.24 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$0.77 per share Price / Book0.68Miscellaneous Outstanding Shares74,440,000Free Float67,366,000Market Cap$39.08 million OptionableNot Optionable Beta0.64 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Richard Alan Barasch (Age 70)Chairman of the Board Dr. Daniel Virnich FACHE (Age 45)M.D., MBA, Chief Executive Officer Comp: $614.62kMr. Mihir Arunkumar Shah CPA (Age 46)Chief Financial Officer Comp: $505.13kDr. Yale D. Podnos F.A.C.S. (Age 52)M.D., M.P.H., Chief Medical Officer Comp: $535.36kMr. Jeremy N. Castle M.B.A. (Age 40)Chief Operations Officer Mr. Mark Hueppelsheuser Esq.General CounselMr. Jordan McInerneyChief Development OfficerMore ExecutivesKey CompetitorsPono Capital TwoNASDAQ:PTWOSHL TelemedicineNASDAQ:SHLTConcord Medical ServicesNYSE:CCMCano HealthNYSE:CANOQHims & Hers HealthNYSE:HIMSView All CompetitorsInsiders & InstitutionsKent Lake Capital LLCBought 101,542 shares on 5/16/2024Ownership: 1.597%FourWorld Capital Management LLCBought 250,359 shares on 5/16/2024Ownership: 0.337%Element Pointe Advisors LLCSold 199,026 shares on 5/14/2024Ownership: 0.268%Nwam LLCBought 27,679 shares on 5/10/2024Ownership: 0.037%Havencrest Healthcare PartnersSold 8,637 sharesTotal: $18,310.44 ($2.12/share)View All Insider TransactionsView All Institutional Transactions TOI Stock Analysis - Frequently Asked Questions How have TOI shares performed this year? Oncology Institute's stock was trading at $2.04 at the start of the year. Since then, TOI shares have decreased by 74.2% and is now trading at $0.5258. View the best growth stocks for 2024 here. How were Oncology Institute's earnings last quarter? The Oncology Institute, Inc. (NASDAQ:TOI) announced its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.10. The business had revenue of $94.67 million for the quarter, compared to the consensus estimate of $95.17 million. Oncology Institute had a negative trailing twelve-month return on equity of 109.10% and a negative net margin of 20.28%. How do I buy shares of Oncology Institute? Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TOI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
